This product is a recombinant Human antibody that can recognize H3N2 HA. H3v-47 exhibits potent cross-reactive neutralization activity against human and swine H3N2 viruses that circulated since 1989. H3v-47 functions primarily by inhibiting viral egress and also effectively engages Fc receptor to elicit ADCC activity. H3v-47 targets a unique conformational epitope spanning the RBS and vestigial esterase region in the HA head mainly using the complementarity determining regions (CDRs) H2 and H3 from the heavy chain and L1 and L3 from the light chain.
Figure 1 Prophylactic and therapeutic efficacy of mAb H3v-47 in mice.
The protective efficacy of mAbs was assessed by virus titers in lungs on 4 dpi (a, b). Dots in a, b indicate individual mice (n = 5 mice per group). The median titer is shown with the line, and the dotted line indicates the limit of detection (LOD).
Bangaru, S., Zhang, H., Gilchuk, I. M., Voss, T. G., Irving, R. P., Gilchuk, P., ... & Richt, J. A. (2018). A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nature communications, 9(1), 2669.
Figure 2 H3v-47 mAb exhibits ADCC activity.
a Cross-linking of FcγRlla. Binding curves were obtained by performing ELISA with serial dilutions of each antibody (H3v-47, H3v-12, or control mAb VRCO1 [to HIV]) onto HA-coated plates and assessing the ability of HA-bound mAbs to engage both Fc-binding sites on the soluble FcγRlla dimer. b Primary NK cell activation. Antibody (H3v-47, H3v-12, or VRC01) were added independently on 96-well plates coated with purified A/Sydnev/5/1997 H3 HA and incubated for 2h. The plates were washed, and 5 x 10⁵ purified NK cells were added to each well. The cells were stained with anti-human CD107a allophycocyanin-H7 Ab, anti-human CD3 PerCP, anti-human CD56 allophycocvanin, and anti-IFNγ AF700.
Bangaru, S., Zhang, H., Gilchuk, I. M., Voss, T. G., Irving, R. P., Gilchuk, P., ... & Richt, J. A. (2018). A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nature communications, 9(1), 2669.
Figure 3 Inhibition of egress of A/Minnesota/11/2010 H3N2v virus by IgG of mAbs H3v-47 or CR8020 or by the small molecule neuraminidase inhibitor zanamivir.
Dotted line represents virus titer in supernatant in the absence of antibody treatment. The experiment was conducted three times independently. The hemagglutination assay to determine virus titer was also conducted three times independently (n-3). The significance in the reduction of HA titer between H3v-47 and CR8020 was calculated at each concentration using 2-way ANOVA and displayed on the graph as ***(P< 0.001).
Bangaru, S., Zhang, H., Gilchuk, I. M., Voss, T. G., Irving, R. P., Gilchuk, P., ... & Richt, J. A. (2018). A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nature communications, 9(1), 2669.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-0094LC | Recombinant Mouse Anti-H3N2 HA Antibody (170) | ELISA, WB | IgG2a |
EPAF-0115LC | Recombinant Mouse Anti-H3N2 HA Antibody (203) | ELISA | IgG1 |
EPAF-0120LC | Recombinant Mouse Anti-H3N2 HA Antibody (207) | ELISA | IgG1 |
EPAF-0128LC | Recombinant Mouse Anti-H3N2 HA Antibody (221) | ELISA | IgG2b |
EPAF-0180LC | Recombinant Mouse Anti-H3N2 HA Antibody (261) | ELISA | IgG2a |
There are currently no Customer reviews or questions for PABC-404. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.